Literature DB >> 10799560

The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis.

J C Wang1, J M Stafford, D K Scott, C Sutherland, D K Granner.   

Abstract

Glucocorticoids stimulate gluconeogenesis by increasing the rate of transcription of genes that encode gluconeogenic enzymes such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase. Previous studies have shown that hepatic nuclear factor 3 (HNF3) is required as an accessory factor for several glucocorticoid-stimulated genes, including PEPCK. Here, we show that adenovirus-mediated expression of an HNF3beta protein with a deleted C-terminal transactivation domain (HNF3betaDeltaC) reduces the glucocorticoid-induced expression of the PEPCK and glucose-6-phosphatase genes in H4IIE hepatoma cells. Furthermore, expression of this truncated HNF3 protein results in a proportionate reduction of glucocorticoid-stimulated glucose production from lactate and pyruvate in these cells. The expression of HNF3betaDeltaN, in which the N-terminal transactivation domain is deleted, does not exhibit any of these effects. These results provide direct evidence that members of the HNF3 family are required for proper regulation of hepatic gluconeogenesis. Modulation of the function of the HNF3 family of proteins might be used to reduce the excessive hepatic production of glucose that is an important pathophysiologic feature of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799560     DOI: 10.1074/jbc.275.19.14717

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  FoxOs function synergistically to promote glucose production.

Authors:  Rebecca A Haeusler; Klaus H Kaestner; Domenico Accili
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

Review 2.  Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues.

Authors:  Rucha Patel; Jasmine Williams-Dautovich; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-04-25

3.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression.

Authors:  J Nakae; T Kitamura; D L Silver; D Accili
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans.

Authors:  Sanjeev K Sharma; Ulrike Leinemann; Regine Ratke; Elke Oetjen; Roland Blume; Corinna Dickel; Willhart Knepel
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

5.  Functional analyses of the mutation nt-128 T→G in the hepatocyte nuclear factor-1α promoter region in Chinese diabetes pedigrees.

Authors:  Q Fang; S Chen; Y Wang; S Jiang; R Zhang; C Hu; C Wang; F Liu; K Xiang; W Jia
Journal:  Diabet Med       Date:  2012-11       Impact factor: 4.359

6.  Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.

Authors:  M A Perera; R K Thirumaran; N J Cox; S Hanauer; S Das; C Brimer-Cline; V Lamba; E G Schuetz; M J Ratain; A Di Rienzo
Journal:  Pharmacogenomics J       Date:  2008-09-30       Impact factor: 3.550

7.  Insulin and epidermal growth factor suppress basal glucose-6-phosphatase catalytic subunit gene transcription through overlapping but distinct mechanisms.

Authors:  Hiroshi Onuma; James K Oeser; Bryce A Nelson; Yingda Wang; Brian P Flemming; Lawrence A Scheving; William E Russell; Richard M O'Brien
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

8.  Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB.

Authors:  Rolf Grempler; Anne Kienitz; Torsten Werner; Marion Meyer; Andreas Barthel; Fabienne Ailett; Calum Sutherland; Reinhard Walther; Dieter Schmoll
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

9.  AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C/EBPβ/E3 Ubiquitin Ligase Signaling pathway.

Authors:  Vishal Kothari; Jeganathan Ramesh Babu; Suresh T Mathews
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

10.  The nuclear receptor cofactor, receptor-interacting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor.

Authors:  Birger Herzog; Magnus Hallberg; Asha Seth; Angela Woods; Roger White; Malcolm G Parker
Journal:  Mol Endocrinol       Date:  2007-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.